Hyperglycemia induces retinal pigmented epithelial cell apoptosis and mitochondrial stress via poorly understood mechanisms. The goal of our current study is to explore whether mammalian sterile 20-like kinase 1 (Mst1) is involved in the pathogenesis of hyperglycemia-mediated retinal pigmented epithelial cell apoptosis by triggering mitochondrial abnormalities and activating the Smad2 signaling pathway. Retinal pigmented epithelial ARPE-19 cells were presented with a high-glucose challenge in vitro. Cell viability and apoptosis were measured via western blotting, ELISAs, and immunofluorescence assays. Mitochondrial function was detected via JC-1 staining, mitochondrial ROS flow cytometry, western blotting, and ELISAs. Loss-and gainof-function assays were performed via cell transfection and transduction with Mst1 siRNA and Smad2 adenovirus, respectively. The results indicated that hyperglycemia treatment upregulated the levels of Mst1, an effect that was accompanied by an increase in ARPE-19 cell apoptosis. Loss of Mst1 attenuated hyperglycemia-induced cell apoptosis, and this effect seemed to be associated with mitochondrial protection. In response to hyperglycemia stimulus, mitochondrial stress was noted in ARPE-19 cells, including mitochondrial ROS overproduction, mitochondrial respiratory metabolism dysfunction, mitochondrial fission/fusion imbalance, and mitochondrial apoptosis activation. Further, we provided evidence to support the crucial role played by Smad2 in promoting Mst1-mediated cell apoptosis and mitochondrial stress. Overexpression of Smad2 abrogated the beneficial effects of Mst1 deletion on ARPE-19 cell viability and mitochondrial protection. Altogether, our results identified Mst1 as a novel mediator controlling the fate of retinal pigmented epithelial cells and mitochondrial homeostasis via the Smad2 signaling pathway. Based on this finding, strategies to repress Mst1 upregulation and block Smad2 activation are vital to alleviate hyperglycemia-mediated retinal pigmented epithelial cell damage.
Introduction
Diabetic retinopathy (DR), known as a diabetic microvascular complication, is one of the main causes of blindness globally (Bikfalvi 2017) . Chronic hyperglycemia stress induces blockade of tiny blood vessels and progressively causes retinal ischemia and nutrient deficiencies. Massive apoptosis of retinal pigmented epithelial cells contributes to micro-aneurysm formation, which is closely followed by abnormal blood vessel proliferation and intraretinal hemorrhages, gradually leading to vision impairment (Blackburn et al. 2017) . Although several attempts have been made to understand the pathogenesis of DR, the precise molecular mechanism underlying the hyperglycemia-mediated retinal pigmented epithelial cell apoptosis has not been adequately explored (Zhu et al. 2016) .
Mammalian sterile 20-like kinase 1 (Mst1) has been originally reported as the apoptotic inducer for several types of cells, such as cardiac microvascular endothelial cells, HepG2 hepatocellular carcinoma cells, neural stem cells, and aortic dissection smooth muscle cells (Buijs et al. 2017; Das et al. 2017; Hambright et al. 2017) . Subsequent studies further report that Mst1 is primarily activated by chronic high-glucose stress and that increased Mst1 causes islet cell dysfunction, promotes diabetic cardiomyopathy, and inhibits angiogenesis Yang et al. 2017) . These information hint to us that Mst1 activation might play a key role in the development of hyperglycemia-mediated retinal pigmented epithelial cell apoptosis and DR progression. However, this notion remains to be confirmed (Kalyanaraman 2017) .
At the molecular level, chronic hyperglycemia promotes excessive accumulation of glucose in retinal pigmented epithelial cells (Chang et al. 2017a; Conradi et al. 2017) . Increased glucose metabolism enhances ROS production in the mitochondrion, and this process evokes cell oxidative stress. Moreover, to rapidly breakdown glucose, mitochondria divide into several fragments via mitochondrial fission (Sheng et al. 2018) . However, abnormal mitochondrial fission produces immature daughter mitochondria with fragmentary mitochondrial DNA and mitochondrial respiratory complex deficiency (Zhou et al. 2017b) , ultimately impairing cellular energy metabolism. More severely, aberrant mitochondrial fission activates the caspase-9-related mitochondrial death pathway Kozlov et al. 2017) , leading to loss of functional cells. In the development of DR, mitochondrial stress, such as mitochondrial oxidative stress, mitochondrial DNA base mismatch, mitochondrial autophagy delay, and mitochondrial metabolism reprogramming, have been reported (Ghiroldi et al. 2017; Giatsidis et al. 2018; Iggena et al. 2017) . There is strong evidence supporting the role of mitochondria in controlling the fate of retinal pigmented epithelial cells, suggesting that further studies should be conducted to fully explore the upstream mediators of mitochondrial stress under high-glucose stimulus.
The Smad pathway is a classical pathway responsible for hyperglycemia-mediated epithelial-mesenchymal transition in human retinal pigment epithelium cells Lee and Back 2017) . Moreover, activated Smad promotes retinal fibrosis. In addition, robust data from animal studies and cell experiments have demonstrated a strong correlation between Smad activation and mitochondrial injury in various disease models, such as angiotensin II-induced renal tubular epithelial cell damage, glioblastoma multiforme metastasis, fatty liver disease, and uric acid-mediated kidney inflammation response models (Hong et al. 2017; Romero et al. 2017) . Mechanistically, Smad2 has been shown to be a transcription factor that regulates gene expression related to mitochondrial dynamics (Hassanshahi et al. 2017; Hooshdaran et al. 2017 ). In addition, Smad2 indirectly affects mitochondrial function by repressing mitochondrial Sirt3 activity and improving ROS production (Liu and Desai 2015; Zhou et al. 2018d ). However, little evidence is available to explain the detailed role played by Smad2 in hyperglycemia-mediated mitochondrial stress. Altogether, the aim of our study was to determine whether Mst1 modulates the pathogenesis of hyperglycemiamediated retinal pigmented epithelial cell apoptosis by inducing mitochondrial stress in a manner dependent on the Smad2 signaling pathway (Zhou et al. 2018g ).
Methods and material

Cell culture and treatment
Retinal pigmented epithelial ARPE-19 cells (ATCC® CRL-2302™) were obtained from American Type Culture Collection (Manassas, VA, USA). The cells were cultured in DMEM supplemented with 10% FBS under 37°C/5% CO 2 conditions. Control group cells were cultured in normal glucose medium (5.5 mmol/L). To induce high-glucose stress, high-glucose medium (25 mmol/L) was applied for 12 h. Meanwhile, cells cultured in mannitol medium (20 mmol/l mannitol + 5.5 mmol/l glucose, Sigma-Aldrich, USA) served as the control group for high-glucose stress. To inhibit Mst1 expression, ARPE-19 cells were transfected with siRNA against Mst1. In addition, Mst1-deleted cells were infected with Smad2 adenovirus to induce Smad2 overexpression (Kelly et al. 2017) .
Western blotting analysis
Cells were scraped in RIPA lysis buffer (Beyotime, Shenzhen, Guangdong, China). The lysates (50-70 μg) were separated by 10% SDS-polyacrylamide gel (10-15%) electrophoresis (SDS-PAGE). Proteins were electrotransferred onto the pure nitrocellulose blotting membrane (Life Sciences) (Millipore, Bedford, MA, USA) and then blocked with 5% nonfat milk for 2 h at room temperature . After washing with TBST three times, the membranes were incubated at 4°C overnight with the following primary antibodies: Bcl2 (1:1000, Cell Signaling Technology, #3498), Bax (1:1000, Cell Signaling Technology, #2772), caspase-9 (1:1000, Cell Signaling Technology, #9504), pro-caspase-3 (1:1000, Abcam, #ab13847), cleaved caspase-3 (1:1000, Abcam, #ab49822), survivin (1:1000, Cell Signaling Technology, #2808), complex III subunit core (CIII-core2, 1:1000, Invitrogen, #459220), complex II (CII-30, 1:1000, Abcam, #ab110410), complex IV subunit II (CIV-II, 1:1000, Abcam, #ab110268), Drp1 (1:1000, Abcam, #ab56788), Fis1 (1:1000, Abcam, #ab71498), Opa1 (1:1000, Abcam, #ab42364), Mfn2 (1:1000, Abcam, #ab56889), Mff (1:1000, Cell Signaling Technology, #86668), Mst1 (1:1000, Cell Signaling Technology, #3682), Tom20 (1:1000, Abcam, #ab186735), and Smad2 (1:1000, Abcam, #ab33875). After washing with TBST, the membranes were incubated with horseradish peroxidase-coupled secondary antibodies (1:2000; cat. nos. 7074 and 7076; Cell Signaling Technology, Inc.) for 1 h at room temperature. GAPDH was used as a reference to calculate the expression of the target proteins. The proteins were visualized using Pierce enhanced chemiluminescence western blotting substrate (Pierce; Thermo Fisher Scientific, Inc.) and autoradiography. Subsequently, the blots were analyzed using Quantity One 4.6 software (Bio-Rad Laboratories, Inc., Hercules, CA, USA) (Karwi et al. 2017; Liu et al. 2017a) . The experiments were performed in triplicate and repeated three times with similar results.
ELISA
To analyze changes in caspase-9, caspase-9 activity kits (Beyotime Institute of Biotechnology, China; Catalog No. C1158) were used according to the manufacturer's protocol. In brief, to measure caspase-9 activity, 5 μl of LEHD-p-NA substrate (4 mM, 200 μM final concentration) was added to the samples for 1 h at 37°C. Then, the absorbance at 400 nm was recorded via a microplate reader to reflect the caspase-3 and caspase-9 activities. To analyze caspase-3 activity, 5 μl of DEVD-p-NA substrate (4 mM, 200 μM final concentration) was added to the samples for 2 h at 37°C. The levels of antioxidant factors, including GPX, SOD, and GSH, were measured with ELISA kits purchased from the Beyotime Institute of Biotechnology (Blackburn et al. 2017) . The experiments were performed in triplicate and repeated three times with similar results.
Immunofluorescence
Cells were washed twice with PBS, permeabilized in 0.1% Triton X-100 overnight at 4°C. After the fixation procedure, the sections were cryoprotected in a PBS solution supplemented with 0.9 mol/l of sucrose overnight at 4°C. The primary antibodies used in the present study were as follows: Tom20 (1:1000, Abcam, #ab186735) and Smad2 (1:1000, Abcam, #ab33875). Subsequently, samples were incubated with Alexa Fluor 488 donkey anti-rabbit secondary antibody (1:1000; cat. no. A-21206; Invitrogen; Thermo Fisher Scientific, Inc.) for~1 h at room temperature. DAPI was used to label the nuclei, and images were captured using an inverted microscope (magnification, × 40; BX51; Olympus Corporation, Tokyo, Japan) (Zhou et al. 2018i ).
Quantitative real-time PCR
For mRNA expression analysis, total RNA was isolated using Trizol (Invitrogen, Carlsbad, California, USA) according to a previous study. Then, cDNA was synthesized using 1 mg RNA and the First-Strand Synthesis Kit (Fermentas, Flamborough, Ontario, Canada) according to a previous study (Zhou et al. 2018f; Zhu et al. 2018a ). The cycling conditions were as follows: 92°C for 7 min, 40 cycles of 95°C for 20 s, and 70°C for 45 s. β-actin was amplified as an internal standard. All primer sequences are listed below: Drp1 (forward primer 5′-CATGGACGAGCTGGCCTTC-3′, reverse primer 5′-ATCCTGTAGTGATGTATCAGG-3′), Fis1 (forward primer 5′-TGTCCAGTCCGTAACTGAC-3′, reverse primer 5′-TTCGATACCTGACTTAC-3′), Mfn2 (forward primer 5′-CCTCTTGATCCTGATCTTAACGT-3′, reverse primer 5′-GGACTACCTGATTGTCATTC-3′), Mff (forward primer 5′-ATGCAGACAATTAAGTGTGTTGTTGTGGGCGA-3′, reverse primer 5′-reverse primer, TCATAGCAGCACAC ACCTGCGGCTCTTCTT-3′), OPA1 (forward primer 5′-GCTACTTGTGAGGTCGATTC-3′, reverse primer 5′-GCCGTATACCGTGGTATGTCTG-3′).
Mitochondrial potential analysis
To observe the mitochondrial potential, JC-1 staining (Thermo Fisher Scientific Inc., Waltham, MA, USA; catalog no. M34152) was used (Shi et al. 2018) . Then, 10 mg/ml JC-1 was added to the medium for 10 min at 37°C in the dark to label the mitochondria. Normal mitochondrial potential showed red fluorescence, and damaged mitochondrial potential showed green fluorescence ).
Mitochondrial ROS analysis
Flow cytometry was applied as a quantitative method for evaluating mitochondrial ROS levels according to a previous study. Cells were seeded onto 6-well plates and then treated with erlotinib. Subsequently, the cells were isolated using 0.25% trypsin and then incubated with MitoSOX red mitochondrial superoxide indicator (Molecular Probes, USA) for 30 min in the dark at 37°C. Subsequently, PBS was used to wash cell two times, and then the cells were analyzed with a FACSCalibur flow cytometer. Data were analyzed by FACS Diva software. The experiment was repeated three times to improve the accuracy (Kleinbongard et al. 2017; Korbel et al. 2018 ).
TUNEL staining and MTT assay
Apoptotic cells were detected with an In Situ Cell Death Detection Kit (Thermo Fisher Scientific Inc., Waltham, MA, USA; catalog no. C1024) according to the manufacturer's protocol. Briefly, cells were fixed with 4% paraformaldehyde at 37°C for 15 min. Blocking buffer (3% H 2 O 2 in CH 3 OH) was added to the wells, and then cells were permeabilized with 0.1% Triton X-100 in 0.1% sodium citrate for 2 min on ice. The cells were incubated with TUNEL reaction mixture for 1 h at 37°C. DAPI (Sigma-Aldrich, St. Louis, MO, USA) was used to counterstain the nuclei, and the numbers of TUNELpositive cells were recorded. MTT was used to analyze the cellular viability. Cells (1 × 10 6 cells/well) were cultured on a 96-well plate at 37°C with 5% CO 2 . Then, 40 μl of MTT solution (2 mg/ml; Sigma-Aldrich) was added to the medium for 4 h at 37°C with 5% CO 2 . Subsequently, the cell medium was discarded, and 80 μl of DMSO was added to the wells for 1 h at 37°C with 5% CO 2 in the dark. The OD of each well was observed at A490 nm via a spectrophotometer (Epoch 2; BioTek Instruments, Inc., Winooski, VT, USA) ).
Transfections
Transfection with siRNA was used to inhibit Mff expression. Two independent siRNAs (siRNA1-Mst1 and siRNA2-Mst1, Yangzhou Ruibo Biotech Co., Ltd., Yangzhou, China) were used to infect cells using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol . Briefly, the cells were seeded onto 6-well plates and then incubated with Opti-Minimal Essential Medium (Invitrogen; Thermo Fisher Scientific, Inc.) for 24 h (Koentges et al. 2017) . Then, Lipofectamine® 2000 transfection reagent (Thermo Fisher Scientific, Inc.) was added into the medium of cells and supplemented with 5 nmol/l siRNA solution. Transfection was performed for 48 h, and then the cells were collected. Western blotting was used to verify the transfection efficiency (Liu et al. 2017b ).
Statistical analysis
Image intensity was quantified using Nikon NIS-Elements-AR software. ImageJ software (NIH, MD, USA) was used to quantify the protein levels on western blots. The data were analyzed using one-way ANOVA followed by Tukey s test for post hoc analysis. The data are presented as the means ± SEM., and differences were deemed significant when p < 0.05.
Results
Mst1 deletion protects ARPE-19 cells against hyperglycemia-induced cell apoptosis
First, ARPE-19 cells were treated with high-glucose medium (25 mmol/l) for 12 h to induce hyperglycemic stress. Meanwhile, to rule out the effect of osmolarity on cell viability, mannitol was added to the medium of control group cells. Then, western blotting was performed to analyze the expression of Mst1. Compared with the control group and mannitol group, the expression of Mst1 was rapidly increased in response to high-glucose treatment (Fig. 1a-b) . Subsequently, to establish a relationship between Mst1 upregulation and ARPE-19 cell viability, ARPE-19 cells were transfected with two independent siRNAs against Mst1, and the knockdown efficiency was confirmed via western blotting, as shown in Fig. 1a-b . After silencing of Mst1, the viability of ARPE-19 cells was determined via MTT assays and trypan blue staining. As shown in Fig. 1c -e, compared with the control and mannitol groups, high-glucose stimulus significantly reduced cell viability and increased the number of trypan blue-positive cells. Interestingly, hyperglycemia-mediated cell apoptosis was abolished by Mst1 knockdown, suggesting that Mst1 upregulation accounted for the hyperglycemia-induced apoptosis in ARPE-19 cells. This finding was further validated via an LDH release assay, which demonstrated Mst1 deletion attenuated hyperglycemia-mediated ARPE-19 cell damage (Fig. 1f) . Subsequently, flow cytometry was used to further quantify cell apoptosis. As shown in Fig. 1g -i, compared with the control and mannitol groups, the apoptotic index of ARPE-19 cells was significantly increased upon exposure to hyperglycemia stimulus. Interestingly, both the early apoptosis rate and late apoptosis score was reduced by Mst1 deletion (Fig. 1g-i) . Altogether, the above data indicate that Mst1, primarily activated by hyperglycemia stress, promotes ARPE-19 cell apoptosis.
Mst1 activation causes mitochondrial energy metabolism disorder
Mitochondria are the energy centers of cell metabolism, and 90% of cellular ATP is supplied by mitochondria (Zhou et al. 2018h) . However, compared with the control and mannitol groups, ATP production was significantly reduced in response to hyperglycemia stress (Fig. 2a) , and this effect was reversed by Mst1 deletion. At the molecular level, mitochondria generate ATP via breakdown of glucose into NADH and electrons, which are captured by mitochondria to generate the mitochondrial membrane potential. Subsequently, with the help of the mitochondrial respiratory complex, mitochondrial membrane potential is converted into ATP, and electrons and NADH interact with each other to form H 2 O. To further observe the mitochondrial energy metabolism, the levels of glucose and lactic acid were measured using ELISAs. As shown in Fig. 2b -c, compared with the control and mannitol group, glucose uptake was obviously repressed by hyperglycemia stress, an effect that was accompanied by a decline in lactic acid production. However, loss of Mst1 reversed the glucose uptake and promoted lactic acid metabolism (Fig. 2b-c) , suggesting that hyperglycemia-interrupted energy disorder could be reversed by Mst1 deletion.
In addition, we found that mitochondrial membrane potential was reduced in hyperglycemia-treated ARPE-19 cells (Fig. 2d-e) , and this alteration was reversed via transfection with Mst1 siRNAs. Western blotting analysis also illustrated that the expression levels of mitochondrial respiratory complex components were drastically downregulated in response to hyperglycemia (Fig. 2f-i) , indicating that high-glucose treatment disturbed mitochondrial respiratory function. However, loss of Mst1 reversed the activity of the mitochondrial respiratory complex. Altogether, these data indicate that hyperglycemia-induced mitochondrial metabolism disturbance is primarily regulated by Mst1 in ARPE-19 cells.
Mst1 elevates mitochondrial fission and represses mitochondrial fusion
Previous studies have reported that mitochondrial fission is activated by hyperglycemia to produce additional daughter mitochondria to accelerate glucose metabolism (Zhou et al. 2018e) . As a consequence of mitochondrial fission activation, interconnective mitochondria are converted to a massive number of fragmented mitochondria, which is harmful for cell viability. In the present study, we asked whether hyperglycemia caused mitochondrial fission in ARPE-19 cells via Mst1. First, qPCR and western blotting were used to detect the transcription and expression of pro-fission proteins. Compared with the control and mannitol groups, the transcription (Fig. 3a-e) and expression ( Fig. 3f-k) of Drp1, Mff, and Fis1 were progressively upregulated in response to hyperglycemia. Interestingly, Mst1 deletion prevented upregulation of these proteins. In contrast to mitochondrial fission, mitochondrial fusion is a repair system that corrects abnormal mitochondrial fission. However, the parameters related to mitochondrial Meanwhile, ARPE-19 cells were also transfected with siRNAs against Mst1, and western blotting was performed to confirm the siRNAs knockdown efficiency after transfection. c MTT assays were used to observe cell viability after transfection with siRNAs in the setting of hyperglycemia stress. d-e Trypan blue staining for dead cells. ARPE-19 cells were treated with high-glucose stress and transfected with Mst1 siRNAs. Then, the number of trypan blue-positive cells was recorded. f LDH release assay for cell damage in response to Mst1 deletion. g-i Annexin/PI staining for apoptotic cells, followed by flow cytometry analysis. Early apoptosis (annexin + /PI − cells) and late apoptosis (annexin + /PI + cells) were measured. *p < 0.05 fusion, such as OPA1, Mfn1, and Mfn2, were significantly downregulated in hyperglycemia-treated cells compared to control and mannitol group cells, indicating that hyperglycemia impaired mitochondrial fusion. Interestingly, loss of Mst1 reversed the transcription (Fig. 3a-e) and expression ( Fig. 3f-k) of mitochondrial fusion factors. Altogether, the above data indicate that mitochondrial fission is activated whereas mitochondrial fusion is repressed by hyperglycemia via Mst1. This finding was further supported by analyzing the average length of mitochondria. Compared with the control and mannitol groups, mitochondria length was reduced to1
.3 μm after exposure to hyperglycemia (Fig. 3l-m) . However, loss of Mst1 reversed the decrease in mitochondrial length, extending the average length to~4.6 μm, despite treatment with high-glucose medium. In addition, we observed massive round and fragmented mitochondria in hyperglycemia-treated APRE-19 cells whereas this phenotypic alteration was reversed by Mst1 (Fig. 3l-m) . Taken together, these results further confirm that hyperglycemia-modulated mitochondrial fission and fusion via Mst1.
Mst1 activates caspase-9-related mitochondrial apoptosis
Excessive mitochondrial fission has been verified to be associated with mitochondrial apoptosis activation (Nawaz et al. 2018; Zhou et al. 2018a ). Based on this information, we observed the alterations in mitochondrial apoptosis in response to Fig. 2 Mitochondrial respiratory function is regulated by Mst1 under hyperglycemia stimulus. a Cellular ATP production was measured in ARPE-19 cells treated with hyperglycemia and/or transfected with Mst1 siRNA. b-c The levels of glucose uptake and lactic acid production were quantified via ELISAs. d-e Mitochondrial membrane potential was assessed using JC-1. The fluorescence intensity of the red-to-green ratio was used to quantify the mitochondrial membrane potential. ARPE-19 cells were treated with hyperglycemia and/or transfected with Mst1 siRNAs. f-i After treatment, proteins were isolated, and the expression levels of mitochondrial respiratory complex components were determined using western blotting. ARPE-19 cells were treated with hyperglycemia and/or transfected with Mst1 siRNAs.*p < 0.05
Mst1 deletion in the setting of hyperglycemia challenge. Early mitochondrial apoptosis is characterized by overproduction of mitochondrial ROS. With the help of flow cytometry, we found that the mitochondrial ROS levels were significantly increased in hyperglycemia-treated cells (Fig. 4a-b) . However, loss of Mst1 attenuated the mitochondrial ROS overload. In addition, ELISAs were used to detect alterations in cellular antioxidant levels. Compared with the control and mannitol group, hyperglycemia treatment obviously reduced the levels of GSH, SOD, and GPX (Fig. 4c-e) , suggesting redox imbalance under hyperglycemia stress. However, loss of Mst1 reversed the changes in GSH, SOD, and GPX content. In addition, a feature of late mitochondrial apoptosis is long-lasting opening of the mitochondrial permeability transition pore (mPTP). In the present study, we found that hyperglycemia treatment promoted opening of the mPTP, and this effect was abolished by Mst1 deletion (Fig. 4f) . The above data indicated that mitochondrial apoptosis was activated by Mst1 at different stages. Last, western blotting analysis was carried out to evaluate the expression of mitochondrial apoptotic proteins under hyperglycemia stress and Mst1 deletion. As shown in Fig. 4g -l, compared with the control group, the expression of pro-apoptotic factors, such as caspase-9, capsase-3, and Bax, was significantly increased in response to high-glucose treatment. In contrast, the levels of anti-apoptotic factors, including Bcl-2 and survivin ( Fig. 4g-l) , were rapidly downregulated upon exposure to high-glucose Fig. 4 Mst1 initiates the caspase-9-related mitochondrial apoptotic pathway. a-b Flow cytometry analysis of mitochondrial ROS production. ARPE-19 cells were treated with hyperglycemia and/or transfected with Mst1 siRNAs. c-e The concentrations of cellular antioxidants, specifically, GSH, SOD, and GPX, were measured using ELISAs in ARPE-19 cells treated with hyperglycemia and/or transfected with Mst1 siRNAs. f The mPTP opening rate in ARPE-19 cells under hyperglycemia treatment and with Mst1 deletion. g-l ARPE-19 cells were treated with hyperglycemia and/or transfected with Mst1 siRNAs. Then, proteins were isolated, and the expression of mitochondrial apoptosis pathway components was analyzed. *p < 0.05 conditions. Notably, loss of Mst1 corrected the anti-apoptotic protein expression and prevented upregulation of pro-apoptotic factors ( Fig. 4g-l) . Altogether, these results indicate that caspase-9-related mitochondrial apoptosis is activated by hyperglycemia via Mst1 in APRE-19 cells.
Smad2 was activated by Mst1 and contributed to hyperglycemia-mediated ARPE-19 cell apoptosis Subsequently, we explored the mechanism by which Mst1 modulates ARPE-19 cell viability and mitochondrial homeostasis. Previous studies have proposed that Smad2 is a key signal transmitter in the setting of hyperglycemia stress (Koentges et al. 2017; Koopman et al. 2017) . Based on this, we asked whether Smad2 is required for Mst1-modulated ARPE-19 apoptosis and mitochondrial stress. First, western blotting demonstrated that the expression of Smad2 was rapidly increased in response to hyperglycemia, and this effect was repressed by Mst1 deletion (Fig. 5a-b) . These data suggested that Mst1 could be considered an upstream regulator of Smad2 in the setting of hyperglycemia stress. This finding was further supported via immunofluorescence assays.
The fluorescence intensity of Smad2 (Fig. 5c-d) was rapidly elevated upon exposure to hyperglycemia. Subsequently, to verify whether Smad2 is necessary for Mst1-mediated ARPE-19 cell apoptosis, ARPE-19 cells were infected with Smad2-carrying adenovirus. The Smad2 overexpression efficiency was verified via western blotting (Fig. 5a-b) and an immunofluorescence assay (Fig. 5c-d) . Then, cell viability was measured via MTT assays in response to Smad2 overexpression. As shown in Fig. 5e , compared with the control and mannitol groups, hyperglycemia-repressed cell viability was reversed by Mst1 deletion. However, overexpression of Smad2 reduced cell viability despite Mst1 deletion (Fig. 5e) . These findings were further validated via TUNEL staining. As shown in Fig. 5f -g, after treatment with high-glucose stress, the percentage of TUNEL-positive cells increased by~46% compared with the control and mannitol group cells. However, loss of Mst1 attenuated the cell death ratio whereas Smad2 overexpression elevated the TUNELpositive ratio compared with the hyperglycemia group ( Fig. 5f-g ). Altogether, these data indicate that Smad2 is activated by hyperglycemia and contributes to ARPE-19 cell apoptosis. 
Mst1-activated Smad2 also regulates mitochondrial stress
Finally, we sought to examine whether Smad2 was also involved in Mst1-modified mitochondrial stress under hyperglycemia conditions. First, mitochondrial ROS production was detected via flow cytometry. Compared with the control and mannitol groups, the mitochondrial ROS levels were progressively increased in response to hyperglycemia stress, and this effect was negated by Mst1 deletion (Fig. 6a) . Interestingly, overexpression of Smad2 re-induced mitochondrial ROS overload (Fig. 6a) . Subsequently, ELISA assays demonstrated that hyperglycemia-mediated cellular antioxidant downregulation was reversed by Mst1 deletion (Fig. 6b-d) , and this effect was abolished by Smad2 overexpression. In addition, hyperglycemia upregulated the transcription of pro-fission factors (Fig. 6e-f ) and repressed the transcription of pro-fusion proteins (Fig. 6g-h ). Mst1 deletion reversed the balance between mitochondrial fission and fusion factors in a manner dependent on Smad2 activity (Fig. 6e-h ). In addition, mitochondrial apoptosis was measured by analyzing the activity of caspase-9. Notably, compared with the hyperglycemia group, the mitochondrial apoptosis protein caspase-9 was inactivated by Mst1 deletion (Fig. 6i) , and this effect was negated by Smad2 overexpression. Altogether, our results indicate that Smad2 is also involved in Mst1-mediated mitochondrial stress in the setting of hyperglycemia challenge in ARPE-19 cells.
Discussion
Chronic hyperglycemia stress promotes the death of retinal pigmented epithelial cells through poorly understood mechanisms. In the present study, we provided evidence to support the key role played by Mst1 in inducing apoptosis of retinal pigmented epithelial cells via induction of mitochondrial stress in vitro. We reported that high-glucose treatment upregulated the expression of Mst1 that accounted for mitochondrial dysfunction, including mitochondrial oxidative stress, mitochondrial energy undersupply, mPTP opening, mitochondrial fission upregulation, mitochondrial fusion repression, and mitochondrial apoptosis activation. Subsequently, our data further demonstrated that Mst1 modulated mitochondrial stress and retinal pigmented epithelial cell apoptosis by enhancing Smad2 expression. As far as we know, this is the first study to describe the functional roles of the Mst1-Smad2 signaling pathways in regulating mitochondrial homeostasis and apoptosis in retinal pigmented epithelial cells (Zhou et al. 2017a; Zhou et al. 2018b ). Based on our results, approaches Fig. 6 Smad2 is also involved in Mst1-mediated mitochondrial stress. a Flow cytometry analysis of mitochondrial ROS production. ARPE-19 cells were treated with hyperglycemia, transfected with Mst1 siRNA, and infected with Smad2 adenovirus. b-d The concentrations of the cellular antioxidants GSH, SOD, and GPX were measured using ELISAs in ARPE-19 cells treated with hyperglycemia, transfected with Mst1 siRNA, and infected with Smad2 adenovirus. e-h qPCR assay to examine mitochondrial fission/fusion proteins in ARPE-19 cells treated with hyperglycemia, transfected with Mst1 siRNA, and infected with Smad2 adenovirus. i Caspase-9 activity was determined via ELISA. The relative activity of caspase-9 is presented as the ratio of the activity in the experimental and control groups. *p < 0.05 to repress Mst1 activation and Smad2 upregulation as well as strategies to sustain mitochondrial function are vital to retard or reverse DR development and progression.
The relationship between Mst1 and cell apoptosis has been extensively explored. For example, in diabetic cardiomyopathy, Mst1 is transferred from cardiac microvascular endothelial cells to cardiomyocytes and promotes the death of functional cardiomyocytes (Peterson et al. 2017) . In lung cancer, overexpression of Mst1 affects the feedback loop of p53 and JNK and ultimately exacerbates cancer cell death (Landry et al. 2017) . Moreover, Mst1 is a downstream effector of several anti-cancer drugs such as matrine (Cao et al. 2018 ) and taurine. Recently, careful studies from several laboratories have further demonstrated that Mst1 regulates cell viability by targeting mitochondria (Zhou et al. 2018c ). An early report illustrates that Mst1 affects the copying and expression of mitochondrial threonyl-tRNA synthetase (Reddy et al. 2018) . Subsequent research identifies an interaction between Mst1 and mitochondrial cyclophilin D (Morell et al. 2017) . Recent studies further illustrate that Mst1 modulates mitochondrial apoptosis by inhibiting Bcl-xL phosphorylation and evoking mitochondrial oxidative stress ). In addition, Mst1 disturbs mitophagy and promotes mitochondrial fission in endometriosis (Zhao et al. 2018 ) and diabetic cardiomyopathy (Zhai et al. 2017 ). Our observations are consistent with the previous findings (Jin et al. 2018; Li et al. 2018) . The difference between our experiments and previously reported data is that we comprehensively explain the role played by Mst1 in mitochondrial stress, including mitochondrial energy metabolism, mitochondrial redox balance, mitochondrial fission/fusion, and mitochondrial apoptosis (Tenreiro et al. 2017) . Besides, our findings, which uncovered the molecular mechanism involved in regulating retinal pigmented epithelial cell survival, may answer the following question: what is the key player in induction and aggravation of diabetic retinopathy? Therefore, from a therapeutic perspective, when designing drugs to treat DR, clinicians should bear in mind that Mst1-modified mitochondrial stress is of utmost importance.
Smad2 is a transcription factor that controls gene transcription related to proliferation and fibrosis. In diabetes development, Smad2 participates in muscle remodeling, myocardial fibrosis, glomerular endothelial cell apoptosis, retinal pigment epithelial cell fibrosis (Chang et al. 2017b) , and islet β-cell apoptosis (Pryds et al. 2017 ). In addition, Smad2 induces mitochondrial stress in several disease models. For example, in human glioma cells, mitochondrial membrane potential and mitochondrial apoptosis is regulated via a Smad2-dependent pathway (Schluter et al. 2017) . In chronic obstructive pulmonary disease, Smad2 is activated by miRNA-542-3p/5p and contributes to mitochondrial dysfunction (Turner et al. 2017) , including mitochondrial oxidative stress and mitochondrial ribosomal dysfunction. Moreover, mitochondrial fusion is negatively regulated by the Smad2-RIN1-Mfn2 signaling pathway in neurodegenerative disorders (Zhou et al. 2017c ). In the present study, we found that Smad2 was signaled by Mst1 and Smad2 upregulation was associated with mitochondrial stress and retinal pigmented epithelial cell apoptosis ). This information lays the foundation to help us further understand the role played by Smad2 in diabetic complications.
Taken together, our results reveal functional implications of Mst1 in retinal pigmented epithelial cell apoptosis under constant hyperglycemia stimulation. Meanwhile, the robust regulatory potential of Mst1 in retinal epithelial cell death is achieved by improving Smad2 expression and evoking mitochondrial stress. This finding may provide a new entry point for treating DR by targeting the Mst1-Smad2-mitochondrial stress-signaling pathway.
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